ZD6474, Cetuximab, and Irinotecan in Patients With Metastatic Colorectal Cancer

NCT00436072 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

46

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: ZD6474
DRUG: Cetuximab
DRUG: Irinotecan

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]
[object Object]
[object Object]